Dr.
Darvas developed the first industrialized soloution-
phase combinatorial synthesis
technology (CMT), which was realized by ComGenex, the first European
combinatorial chemistry corporation in 1992.
In the mid-90's Dr. Darvas focused to high-throughput ADME
methodologies in combinatorial design, then to intorduce combinatorial
methodologies into chemical genomics, and, recently, to use micro- and
nanoscale flow reaction technologies for combinatorial synthesis and
lead optimization.
Dr. Darvas received his first degree in organic chemistry, another in
computer science, and his PhD. in the use of artificial intelligence
in drug design. Dr. Darvas is co-founder of the International Society
for QSAR, of the Society for Biomolecular Screening (SBS), and of the
Hungarian Chapter of the American Chemical Society.
